• Afferent (acquired by Merck)

  • Alios (acquired by Johnson+Johnson)

  • Ambit (acquired by Daiichi Sankyo)

  • Ambrx (acquired by Wuxi)

  • Artus (acquired by Qiagen)

  • Avexis (acquired by Novartis)

  • BioFire (acquired by bioMérieux)

  • BioXell (acquired by Cosmo)

  • Care Innovations (acquired by PRA Health Sciences)

  • CGI (acquired by Gilead)

  • DVS (acquired by Fluidigm)

  • Envoy (acquired by Takeda)

  • Flatiron (acquired by Roche)

  • Foundation Medicine (acquired by Roche)

  • HistoRx (acquired by Genoptix)

  • Leukosite (acquired by Millennium)

  • LTI (acquired by Bial)

  • Memory (acquired by Roche)

  • Miikana (acquired by EntreMed)

  • MySugr (acquired by Roche)

  • Pandion (acquired by Merck)

  • Sequana (acquired by Celera)

  • Stratos Genomics (acquired by Roche)

  • Syrrx (acquired by Takeda)

  • Tripath (acquired by Becton Dickinson)

  • Viewics (acquired by Roche)

  • Zikanii (acquired by Eloxx)

  • Addex

  • Aileron

  • Anadys

  • Black Diamond Therapeutics

  • C4 Therapeutics

  • Caliper

  • Complete Genomics

  • Conatus

  • Curetis

  • CV Therapeutics

  • CytomX

  • deCode

  • Fibrogen, Inc

  • Halozyme Therapeutics

  • Horizon Discovery

  • Miragen

  • Pharmasset

  • Protein Design Labs, Inc

  • Senseonics

  • Taimed

  • TiGenix

  • Xenon

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

you go to an external page